Torell John R III

Avg. Two Year Performance

33% Avg. Purchase Return
15% Compound
(9%) Avg. Sale Return
(4%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(< 1%)(2%)6%15%33%
Purchase Success Rate2 of 32 of 33 of 33 of 33 of 3
Average Sale Return3%7%8%9%(9%)
Sale Success Rate1 of 22 of 22 of 22 of 20 of 2

Wyeth

Drugs » Drug Manufacturers - Major

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--